Are rOS kinase fusions common in Chinese patients with cholangiocarcinoma?
ROS fusions are not common in Chinese CCA patients.
Sub-toxic concentrations of bile acids in the range that occur under normal physiological conditions protect HepG2.rNtcp cells against GCDCA-induced apoptosis, which is independent of FXR-controlled changes in bile acid transport.